BMCMI
MED icon

Bryn Mawr Capital Management Inc’s Medifast MED Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,800
Closed -$290K – 180
2015
Q3 		$290K Buy
10,800
+145
+1% +$4.22K 0.05% 367
2015
Q2 		$344K Sell
10,655
-7,089
-40% -$225K 0.05% 342
2015
Q1 		$532K Buy
17,744
+3,448
+24% +$109K 0.07% 231
2014
Q4 		$480K Buy
+14,296
New +$445K 0.06% 257
2014
Q1 		– Sell
-19,861
Closed -$519K – 621
2013
Q4 		$519K Buy
19,861
+5,710
+40% +$146K 0.03% 337
2013
Q3 		$381K Sell
14,151
-1,210
-8% -$32.4K 0.02% 393
2013
Q2 		$396K Buy
+15,361
New +$403K 0.03% 263

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bryn Mawr Capital Management Inc's MED Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of Medifast (MED) in Q4 2015, closing a stake of 10,800 shares — an estimated $290K sold.

Bryn Mawr Capital Management Inc first reported a position in MED in Q2 2013 and held it in 7 quarters. The position peaked at $532K in Q1 2015. 131 funds tracked by Wall St. Rank hold MED as of Q4 2015.

  • Bryn Mawr Capital Management Inc reported no remaining Medifast position as of Q4 2015 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 10,800 Medifast shares in Q4 2015, an estimated $290K.
  • Bryn Mawr Capital Management Inc first reported a position in Medifast in Q2 2013 and held it in 7 quarters.
  • Bryn Mawr Capital Management Inc's Medifast position peaked at $532K in Q1 2015.
  • 131 funds tracked by Wall St. Rank held Medifast as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.